Kronox Lab Sciences Ltd (KRONOX) - Net Assets
Based on the latest financial reports, Kronox Lab Sciences Ltd (KRONOX) has net assets worth Rs1.16 Billion INR (≈ $12.56 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs1.28 Billion ≈ $13.79 Million USD) and total liabilities (Rs113.96 Million ≈ $1.23 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore KRONOX asset base for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs1.16 Billion |
| % of Total Assets | 91.06% |
| Annual Growth Rate | 30.25% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 13.63 |
Kronox Lab Sciences Ltd - Net Assets Trend (2022–2026)
This chart illustrates how Kronox Lab Sciences Ltd's net assets have evolved over time, based on quarterly financial data. Check KRONOX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Kronox Lab Sciences Ltd (2022–2026)
The table below shows the annual net assets of Kronox Lab Sciences Ltd from 2022 to 2026. For live valuation and market cap data, see Kronox Lab Sciences Ltd (KRONOX) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs1.16 Billion ≈ $12.56 Million |
+28.88% |
| 2025-03-31 | Rs901.05 Million ≈ $9.74 Million |
+35.89% |
| 2024-03-31 | Rs663.05 Million ≈ $7.17 Million |
+48.40% |
| 2023-03-31 | Rs446.79 Million ≈ $4.83 Million |
+10.72% |
| 2022-03-31 | Rs403.53 Million ≈ $4.36 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Kronox Lab Sciences Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs371.04 Million | 31.95% |
| Other Components | Rs790.23 Million | 68.05% |
| Total Equity | Rs1.16 Billion | 100.00% |
Kronox Lab Sciences Ltd Competitors by Market Cap
The table below lists competitors of Kronox Lab Sciences Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Korea Computer & Systems Inc
KQ:115500
|
$61.72 Million |
|
WeGrow AG
DU:ZN2
|
$61.75 Million |
|
Senzime AB
ST:SEZI
|
$61.75 Million |
|
Kredyt Inkaso SA
WAR:KRI
|
$61.76 Million |
|
Nurminen Logistics Oyj
HE:NLG1V
|
$61.70 Million |
|
Tong Herr Resources Bhd
KLSE:5010
|
$61.67 Million |
|
China Tianrui Group Cement Company Limited
F:T18
|
$61.67 Million |
|
Glomac Bhd
KLSE:5020
|
$61.66 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kronox Lab Sciences Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 901,049,000 to 1,161,270,000, a change of 260,221,000 (28.9%).
- Net income of 276,600,000 contributed positively to equity growth.
- Dividend payments of 18,550,000 reduced retained earnings.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs276.60 Million | +23.82% |
| Dividends Paid | Rs18.55 Million | -1.6% |
| Other Changes | Rs2.17 Million | +0.19% |
| Total Change | Rs- | 28.88% |
Book Value vs Market Value Analysis
This analysis compares Kronox Lab Sciences Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.89x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 14.14x to 4.89x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-03-31 | Rs10.88 | Rs153.81 | x |
| 2023-03-31 | Rs12.04 | Rs153.81 | x |
| 2024-03-31 | Rs17.87 | Rs153.81 | x |
| 2025-03-31 | Rs24.28 | Rs153.81 | x |
| 2026-03-31 | Rs31.42 | Rs153.81 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kronox Lab Sciences Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.82%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 27.33%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 1.10x
- Recent ROE (23.82%) is below the historical average (31.05%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 33.77% | 16.57% | 1.45x | 1.41x | Rs95.92 Million |
| 2023 | 37.19% | 17.39% | 1.77x | 1.21x | Rs121.49 Million |
| 2024 | 32.20% | 23.76% | 1.21x | 1.12x | Rs147.21 Million |
| 2025 | 28.26% | 25.42% | 1.01x | 1.10x | Rs164.57 Million |
| 2026 | 23.82% | 27.33% | 0.79x | 1.10x | Rs160.47 Million |
Industry Comparison
This section compares Kronox Lab Sciences Ltd's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $12,539,578,100
- Average return on equity (ROE) among peers: 8.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kronox Lab Sciences Ltd (KRONOX) | Rs1.16 Billion | 33.77% | 0.10x | $61.72 Million |
| Aarti Industries Limited (AARTIIND) | $56.05 Billion | 5.90% | 0.98x | $1.91 Billion |
| Aarti Surfactants Limited (AARTISURF) | $2.18 Billion | 9.78% | 0.94x | $44.03 Million |
| ABM International Limited (ABMINTLLTD) | $127.92 Million | -37.56% | 1.23x | $4.33 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $10.31 Billion | 14.16% | 0.12x | $392.05 Million |
| Aether Industries Limited (AETHER) | $20.63 Billion | 4.00% | 0.16x | $2.17 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $2.69 Billion | 18.78% | 1.53x | $1.60 Billion |
| Alkali Metals Limited (ALKALI) | $513.46 Million | 2.20% | 1.13x | $7.55 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $1.50 Billion | 30.09% | 1.66x | $1.01 Billion |
| Ami Organics Limited (AMIORG) | $576.82 Million | 32.06% | 1.70x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $30.82 Billion | 3.03% | 0.71x | $1.49 Billion |
About Kronox Lab Sciences Ltd
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health;… Read more